1887

Abstract

Epstein-Barr virus (EBV) exists in the human population in two genetic forms, usually referred to as type A and type B. Although many earlier studies had indicated that the A type was generally predominant, there were suggestions that the B type may exhibit a preferential tropism for nasopharyngeal epithelial cells. This study examines the prevalence of the two forms of EBV DNA present in nasopharyngeal carcinoma biopsies obtained from the high incidence area of Southern China. The results obtained by Southern blot or polymerase chain reaction analyses show that in this patient group the A type of EBV is predominant.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-2-463
1992-02-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/2/JV0730020463.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-2-463&mimeType=html&fmt=ahah

References

  1. Adldinger H. K., Delius H., Freese U. K., Clarke J., Bornkamm G. W. 1985; A putative transforming gene of Jijoye virus differs from that of Epstein–Barr virus prototypes. Virology 141:221–234
    [Google Scholar]
  2. Arrand J. R., Young L. S., Tugwood J. D. 1989; Two families of sequences in the small RNA-encoding region of Epstein–Barr virus (EBV) correlate with EBV types A and B. Journal of Virology 63:983–986
    [Google Scholar]
  3. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein–Barr virus genome. Nature, London 310:207–211
    [Google Scholar]
  4. Bornkamm G. W., Delius H., Zimber U., Hudewentz J., Epstein M. A. 1980; Comparison of Epstein–Barr virus strains of different origin by analysis of the viral DN As. Journal of Virology 35:603–618
    [Google Scholar]
  5. Bornkamm G. W., Knebel-Doeberitz M. V., Lenoir G. M. 1984; No evidence for differences in the Epstein–Barr virus genome carried in Burkitt’s lymphoma cells and non-malignant lymphoblastoid cells from the same patients. Proceedings of the National Academy of Sciences, U.S.A. 81:4930–4934
    [Google Scholar]
  6. Dambaugh T., Raab-Traub N., Heller M., Beisel C., Hummel M., Cheung A., Fennewald S., King W., Kieff E. 1980; Variation among isolates of Epstein–Barr virus. Annals of the New York Academy of Sciences 354:309–325
    [Google Scholar]
  7. Dambaugh T., Hennessy K., Chamnankit L., Kieff E. 1984; U2 region of Epstein–Barr virus DNA may encode Epstein–Barr nuclear antigen 2. Proceedings of the National Academy of Sciences, U.S.A. 81:7632–7636
    [Google Scholar]
  8. Epstein M. A. 1976; Epstein–Barr virus – is it time to develop a vaccine program?. Journal of the National Cancer Institute 56:697–700
    [Google Scholar]
  9. Epstein M. A., Achong B. G. (editors) 1986 The Epstein–Barr Virus – Recent Advances London: Heinemann;
    [Google Scholar]
  10. Harris A. J., Walsh-Arrand J. E., Crawford D. H., Lenoir G. H., Griffin B. E. 1984; Molecular characterization of the Epstein–Barr virus DNA in three new Burkitt’s lymphoma-derived cell lines. Molecular Biology and Medicine 2:135–150
    [Google Scholar]
  11. Lees J. F., Goodeve A. C., Arrand J. E., Ghosh A. K., Jones P. H., Arrand J. R. 1992; Detection of EBV DNA in postnasal space biopsy tissue from asymptomatic EBV seropositive individuals. Journal of Medical Virology (in press)
    [Google Scholar]
  12. Lung M. L., Chang R. S., Huang M. -L., Guo H. -Y., Choy D., Sham J., Tsao S. -Y., Cheng P., Ng M. -H. 1990; Epstein–Barr virus genotypes associated with nasopharyngeal carcinoma in Southern China. Virology 177:44–53
    [Google Scholar]
  13. Parkin D. M., Stjernsward J., Muir C. S. 1984; Estimates of the worldwide frequency of twelve major cancers. Bulletin of the World Health Organization 62:163–182
    [Google Scholar]
  14. Polack A., Hartl G., Zimber U., Freese U. K., Laux G., Takaki K., Bechet J. -M., Kuklik-Roos C., Wunderlich D., Bornkamm G. W. 1984; A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein–Barr virus isolates. Gene 27:279–288
    [Google Scholar]
  15. Rickinson A. B., Young L. S., Rowe M. 1987; Influence of the Epstein–Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. Journal of Virology 61:1310–1317
    [Google Scholar]
  16. Rowe M., Young L. S., Cadwallader K., Petti L., Kieff E., Rickinson A. B. 1989; Distinction between Epstein–Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA3 family of nuclear proteins. Journal of Virology 63:1031–1039
    [Google Scholar]
  17. Rymo L., Lindahl T., Adams A. 1979; Sites of sequence variability in Epstein–Barr virus DNA from different sources. Proceedings of the National Academy of Sciences, U.S.A. 76:2794–2798
    [Google Scholar]
  18. Sample J., Young L., Martin B., Chatman T., Kieff E., Rickinson A., Kieff E. 1990; Epstein–Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. Journal of Virology 64:4084–4092
    [Google Scholar]
  19. Sixbey J. W., Nedrud J. G., Raab-Traub N., Hanes R. A., Pagano J. S. 1984; Epstein–Barr virus replication in oropharyngeal epithelial cells. New England Journal of Medicine 310:1225–1230
    [Google Scholar]
  20. Sixbey J. W., Lemon S. M., Pagano J. S. 1986; A second site for Epstein–Barr virus shedding: the uterine cervix. Lancet ii:1122–1124
    [Google Scholar]
  21. Sixbey J. W., Shirley P., Chesney P. J., Buntin D. M., Resnick L. 1989; Detection of a second widespread strain of Epstein–Barr virus. Lancet ii:761–765
    [Google Scholar]
  22. Spring S. B., Schluederberg A., Allen W. P., Gruber J. 1989; Pathogenic diversity of Epstein–Barr virus. Journal of the National Cancer Institute 81:13–20
    [Google Scholar]
  23. Tugwood J. D., Lau W. -H., O. S. -K., Tsao S. -Y., Martin W. M. C., Shiu W., Desgranges C., Jones P. H., Arrand J. R. 1987; Epstein–Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. Journal of General Virology 68:1081–1091
    [Google Scholar]
  24. Wolf H., zur Hausen H., Becker V. 1973; Epstein–Barr virus genomes in epithelial nasopharyngeal carcinoma cells. Nature, London 244:245–246
    [Google Scholar]
  25. Yao Q. Y., Rowe M., Martin B., Young L. S., Rickinson A. B. 1991; The Epstein–Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. Journal of General Virology 72:1579–1590
    [Google Scholar]
  26. Young L. S., Yao Q. Y., Rooney C. M., Sculley T. B., Moss D. J., Rupani H., Laux G., Bornkamm G. W., Rickinson A. B. 1987; New type B isolates of Epstein–Barr virus from Burkitt’s lymphoma and from normal individuals in endemic areas. Journal of General Virology 68:2853–2862
    [Google Scholar]
  27. Zimber U., Adldinger H. K., Lenoir G. M., Vuillaume M., Knebel-Doeberitz M., Laux G., Desgranges C., Wittman P., Freese U. K., Schneider U., Bornkamm G. W. 1986; Geographical prevalence of two Epstein–Barr virus types. Virology 154:56–66
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-2-463
Loading
/content/journal/jgv/10.1099/0022-1317-73-2-463
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error